Novartis wins European approval for biosimilar version of Roche's MabThera

June 18, 2017, 10:44 am by Reuters Health News

ZURICH (Reuters) - Swiss drugmaker Novartis on Monday said it had won European approval for its biosimilar version of Roche's blockbuster Rituxan as the crosstown rivals go head-to-head on a drug to treat blood cancers and immunological diseases.

Featured Medical Stories

Have you seen the NEW FITBIT??

Fitbit is now a health tracker and fasion statement. See all the new beautiful models here >> See the HOTTEST new Fitbits!

See the HOT Fitbit Blaze Now Compare All Fitbit Products Google Fitbit

Awaken Your Sleeping Beauty With This Sleep Tracker

Sleep is the new hot topic and from what science tells us, it is the holy grail of health. If you can track it, you can optimize it. If you can optimize it, you can benefit from it. This hot new sleep tracker by Hello is the perfect sleep tracker for the perfect price. There is beauty in health, and it needs to be awakened. But before that, let's get the best sleep of our lives. Learn more here: Sense Sleep Tracker on Amazon

Sleep Tracker on Amazon Sleep Tracker Reviews Google Sleep Trackers

More medical news from Reuters Health News

Philippines deploys troops to a second province to fight bird flu
Reuters Health News : August 20, 2017, 1:36 am
MANILA (Reuters) - The Philippines has deployed more troops to cull thousands of chickens one day after the farm ministry confirmed the spread of bird flu into a second province north of the capital, Manila.

Exclusive: India threatens Philip Morris with 'punitive action' over alleged violations
Reuters Health News : August 18, 2017, 12:30 pm
NEW DELHI (Reuters) - The Indian government has threatened Philip Morris International Inc with "punitive action" over the tobacco giant's alleged violation of the country's anti-smoking laws, according to a letter sent to the company by the federal health ministry.

Insys agrees to pay $4.5 million to resolve Illinois opioid lawsuit
Reuters Health News : August 18, 2017, 11:35 am
(Reuters) - Insys Therapeutics Inc has agreed to pay $4.5 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed a highly addictive fentanyl-based cancer pain drug for off-label uses.

Surgeries to remove weight-loss devices on the rise
Reuters Health News : August 18, 2017, 10:16 am
Reuters Health - Doctors are doing fewer weight-loss procedures to implant adjustable bands around the stomach and more operations to remove the devices or alter them, a U.S. study suggests.

Alcohol may impair tired drivers even if they aren’t drunk
Reuters Health News : August 18, 2017, 9:32 am
Reuters Health - People with blood alcohol levels below the legal cutoff for being considered drunk may still be unsafe drivers if they’re also sleep deprived, a small experiment suggests.